3 Best Healthcare Stocks to Buy in May 2026, According to Analysts

Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

1. Legend Biotech (LEGN)

Legend Biotech is one of Wall Street’s top cell therapy picks. Demand for its CAR‑T cancer therapy remains strong, with revenue growing faster-than-expected. The company is also expanding into earlier‑line treatments, which could open the door to a much larger patient base.

Further, LEGN keeps expanding its manufacturing capacity and has a deep pipeline in both blood cancers and solid tumors. With cell therapy use rising around the world, analysts see Legend as one of the best‑positioned players in the field.

Turning to Wall Street, Legend Biotech stock has a Strong Buy consensus rating based on 10 Buys and one Hold assigned in the last three months. At $55.90, the average LEGN stock price target implies a 102.91% upside potential.